|
Statement of Operations (USD $)
In Thousands, except Share data, unless otherwise specified |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Dec. 31, 2011
|
|
| Revenues: | |||
| Product sales | $ 7,998 | $ 5,178 | $ 1,460 |
| Collaborations, partnerships and other revenues | 3,886 | 1,404 | 1,137 |
| Total revenues | 11,884 | 6,582 | 2,597 |
| Costs and expenses: | |||
| Cost of product sales | 2,302 | 2,089 | 727 |
| Research and development | 16,622 | 14,301 | 13,660 |
| Sales and marketing | 6,516 | 4,398 | 3,031 |
| General and administrative | 10,707 | 8,024 | 6,482 |
| Total costs and expenses | 36,147 | 28,812 | 23,900 |
| Loss from operations | (24,263) | (22,230) | (21,303) |
| Other (expense) income: | |||
| Interest expense | (716) | (34) | (44) |
| Other income | 21 | 0 | 3 |
| Total other expense | (695) | (34) | (41) |
| Net loss | $ (24,958) | $ (22,264) | $ (21,344) |
| Net loss per share of common stock, basic and diluted | $ (3.17) | $ (12.89) | $ (12.47) |
| Weighted average number of shares used in computing net loss per share of common stock, basic and diluted | 7,878,060 | 1,727,086 | 1,711,567 |